Highlights for the fourth quarter and full year 2025 include:
(in millions of | ||||
| Quarter Ended | Year Ended | ||
| 2025 | 2024 | 2025 | 2024 |
Gross written premiums | ||||
Net premiums earned | ||||
Underwriting income (1) | ||||
Net investment income | ||||
Net income | ||||
Combined ratio (1) | 82.0% | 77.8% | 85.9% | 79.9% |
Earnings per share (diluted) (2) | ||||
Return on average equity (annualized) (3) | 18.5% | 18.4% | 18.6% | 22.6% |
Core operating income (3) | ||||
Core operating earnings per share (diluted) (3) | ||||
Core operating return on average equity (annualized) (3) | 19.5% | 25.0% | 16.8% | 24.2% |
Book value per share (1) |
|
| ||
| (1) | See “Supplementary Financial Information” below. | |
| (2) | See “Note to the Consolidated Financial Statements (Unaudited)” below. | |
| (3) | See “Non-GAAP Financial Measures” below. |
“We have built a level of resilience across our Company with the right strategy, exceptional talent and strong execution and capital management capabilities, all of which we believe will continue to hold us in good stead for the years ahead.”
Results for the Quarters and Years ended
The Company generated net income for the quarter ended
Return on average equity (annualized) was 18.5% for the fourth quarter of 2025, compared to 18.4% for the fourth quarter of 2024, and 18.6% for the year ended
Core operating income, a non-GAAP financial measure, was
Gross written premiums were
Underwriting income for the fourth quarter and full year 2025 was
The loss ratio improved to 42.1%, including CAT losses of 11.7%, for the fourth quarter of 2025 from 43.0% which included CAT losses of 6.0% for the fourth quarter of 2024. For the full year 2025, the loss ratio was 47.6%, including CAT losses of 13.0%, compared to 44.7% which included CAT losses of 9.2% for the full year 2024. The increase in the full year 2025 loss ratio primarily resulted from the lower level of net premiums earned.
The expense ratio (which includes net policy acquisition expenses, and general and administrative expenses) was 39.9% and 38.3% for the fourth quarter and full year 2025, respectively, compared to 34.8% and 35.2%, respectively, for the same periods in 2024. The increase in expense ratios were largely driven by higher human resource and IT/software costs, coupled with the impact of lower net premiums earned in 2025 relative to corresponding periods in 2024.
The combined ratio was 82.0% and 85.9% for the fourth quarter and full year 2025, respectively, compared to 77.8% and 79.9%, respectively, for the same periods in 2024.
Segment Results
The Specialty Long-tail Segment, which represented 25% of the Company’s gross written premiums for the year ended
Gross written premiums were
The Specialty Short-tail Segment, which represented 60% of the Company’s gross written premiums for the year ended
Gross written premiums were
The Reinsurance Segment, which represented 15% of the Company’s gross written premiums for the year ended
Gross written premiums were
Investment Results
Investment income increased by 2.2% to
Investment income increased by 5.4% to
Net Foreign Exchange (Loss) Gain
The net foreign exchange loss for the fourth quarter of 2025 was
The net foreign exchange loss for the fourth quarter of 2025 was driven by the negative currency movement in the Company’s major transactional currencies (mainly the Pound Sterling and the Euro) against the
Total Shareholders’ Equity
Total shareholders’ equity increased to
The movement in total shareholders’ equity during the quarter and year ended
(in millions of | Quarter Ended | Year Ended |
Total Shareholders’ equity at beginning of period | ||
Net income | ||
Change in unrealized (loss) gain on available-for-sale investments | ( | |
Purchase of treasury shares (a) | ( | ( |
Issuance of common shares under share-based compensation plan and employees stock purchase plan | ||
Cash dividends declared | ( | ( |
Total shareholders’ equity at |
(a) | In the fourth quarter of 2025, the Company repurchased 343,911 common shares at an average price per share of |
Book value per share grew by 13.9% to
Ordinary Common Share Dividend
On
Consolidated Statements of Income (Unaudited) | ||||
| Quarter Ended | Year Ended | ||
(in millions of | 2025 | 2024 | 2025 | 2024 |
|
|
|
|
|
Gross written premiums | ||||
Ceded written premiums | ( | ( | ( | ( |
Net written premiums | ||||
Net change in unearned premiums | ( | ( | ||
Net premiums earned | ||||
Investment income | ||||
Net realized gain on investments | ||||
Net unrealized (loss) gain on investments | ( | ( | ||
Change in allowance for expected credit losses on investments | — | — | ||
Net investment income | ||||
Other revenues | ||||
Total revenues | ||||
Expenses |
|
|
|
|
Net loss and loss adjustment expenses | ( | ( | ( | ( |
Net policy acquisition expenses | ( | ( | ( | ( |
General and administrative expenses | ( | ( | ( | ( |
Change in allowance for expected credit losses on receivables | ( | ( | ||
Change in fair value of derivative financial liabilities | — | — | — | ( |
Other expenses | ( | ( | ( | ( |
Net Foreign exchange (loss) gain | ( | ( | ( | |
Total expenses | ( | ( | ( | ( |
Income before income taxes | ||||
Income tax credit | — | |||
Net income | ||||
Diluted earnings per share attributable to equity holders (1) | ||||
| (1) | See “Note to the Consolidated Financial Statements (Unaudited)”. |
Consolidated Balance Sheets (Unaudited) | ||
(in millions of | As at | As at |
ASSETS |
|
|
Investments |
|
|
Fixed maturity securities available-for-sale, at fair value | ||
Fixed maturity securities held to maturity | ||
Equity securities, at fair value | ||
Other investments, at fair value | ||
Short-term investments | ||
Term deposits | — | |
Equity-method investments measured at fair value | ||
Total investments | ||
Cash and cash equivalents | ||
Accrued investment income | ||
Premiums receivable | ||
Reinsurance recoverables | ||
Ceded unearned premiums | ||
Deferred policy acquisition costs, net of ceding commissions | ||
Deferred tax assets, net | ||
Other assets | ||
TOTAL ASSETS | ||
|
|
|
LIABILITIES |
|
|
Reserve for unpaid loss and loss adjustment expenses | ||
Unearned premiums | ||
Insurance and reinsurance payables | ||
Other liabilities | ||
TOTAL LIABILITIES | ||
|
|
|
SHAREHOLDERS’ EQUITY |
|
|
Common shares at par value | ||
Additional paid-in capital | ||
— | ( | |
Accumulated other comprehensive gain (loss), net of taxes | ( | |
Retained earnings | ||
TOTAL SHAREHOLDERS’ EQUITY | ||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
|
|
|
Supplementary Financial Information – Combined Ratio (Unaudited) | ||||
| Quarter Ended | Year Ended | ||
| 2025 | 2024 | 2025 | 2024 |
|
|
|
|
|
Loss ratio (a) | 42.1% | 43.0% | 47.6% | 44.7% |
Net policy acquisition expense ratio (b) | 15.8% | 16.6% | 16.9% | 16.5% |
General and administrative expense ratio (c) | 24.1% | 18.2% | 21.4% | 18.7% |
Expense ratio (d) | 39.9% | 34.8% | 38.3% | 35.2% |
Combined ratio (e) | 82.0% | 77.8% | 85.9% | 79.9% |
(a) | Represents net loss and loss adjustment expenses as a percentage of net premiums earned. | |
(b) | Represents net policy acquisition expenses as a percentage of net premiums earned. | |
(c) | Represents general and administrative expenses as a percentage of net premiums earned. | |
(d) | Represents the sum of the net policy acquisition expense ratio and the general and administrative expense ratio. | |
(e) | Represents the sum of the loss ratio and the expense ratio. |
Supplementary Financial Information – Book Value per Share (Unaudited) | ||
(in millions of | As at | As at |
|
|
|
Common shares outstanding (in millions)* | 42.8 | 45.1 |
Minus: Unvested shares (in millions)** | 0.8 | 1.0 |
Number of vested common outstanding shares (in millions) (a) | 42.0 | 44.1 |
|
|
|
Total shareholders’ equity (b) | ||
Book value per share (b)/(a) | ||
* Common shares issued and outstanding as at | |
| No. of shares as at |
| |
Vested common shares as of | 44,117,721 |
154,011 | |
Vested restricted share awards | 475,013 |
Granted employee stock purchase plan | 29,027 |
Cancelled treasury shares | (2,788,114) |
(1,407) | |
Total vested common shares as of | 41,986,251 |
|
|
Unvested restricted shares awards as of | 827,811 |
Unvested employee stock purchase plan as of | 28,154 |
Total unvested shares as of | 855,965 |
Total common shares outstanding as of | 42,842,216 |
** | Restricted Share Awards were issued pursuant to the Company’s 2020 Omnibus Incentive Plan and beneficiaries are entitled to dividends and voting rights. However, the Restricted Share Awards are non-transferable by their holders until they vest per the respective Restricted Share Award Agreements. At |
Supplementary Financial Information - Segment Results (Unaudited) | |||||||
| |||||||
Segment information for IGI’s consolidated operations is as follows: | |||||||
| |||||||
For the quarter ended | |||||||
(in millions of | Specialty |
| Specialty |
| Reinsurance |
| Total |
Underwriting revenues |
|
|
|
|
|
|
|
Gross written premiums |
|
|
| ||||
Ceded written premiums | ( |
| ( |
| — |
| ( |
Net written premiums |
|
|
| ||||
Net change in unearned premiums | ( |
| ( |
|
| ||
Net premiums earned |
|
|
| ||||
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses | ( |
| ( |
| ( |
| ( |
Net policy acquisition expenses | ( |
| ( |
| ( |
| ( |
Underwriting income |
|
|
| ||||
For the quarter ended | |||||||
(in millions of | Specialty |
| Specialty |
| Reinsurance |
| Total |
Underwriting revenues |
|
|
|
|
|
|
|
Gross written premiums |
|
|
| ||||
Ceded written premiums | ( |
| ( |
| — |
| ( |
Net written premiums |
|
|
| ||||
Net change in unearned premiums |
| ( |
|
| |||
Net premiums earned |
|
|
| ||||
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses | ( |
| ( |
| ( |
| ( |
Net policy acquisition expenses | ( |
| ( |
| ( |
| ( |
Underwriting income |
|
|
| ||||
Supplementary Financial Information - Segment Results (Unaudited) | |||||||
| |||||||
For the year ended | |||||||
(in millions of | Specialty |
| Specialty |
| Reinsurance |
| Total |
Underwriting revenues |
|
|
|
|
|
|
|
Gross written premiums |
|
|
| ||||
Ceded written premiums | ( |
| ( |
| ( |
| ( |
Net written premiums |
|
|
| ||||
Net change in unearned premiums |
| ( |
| ( |
| ( | |
Net premiums earned |
|
|
| ||||
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses | ( |
| ( |
| ( |
| ( |
Net policy acquisition expenses | ( |
| ( |
| ( |
| ( |
Underwriting income |
|
|
| ||||
For the year ended | |||||||
(in millions of | Specialty |
| Specialty |
| Reinsurance |
| Total |
Underwriting revenues |
|
|
|
|
|
|
|
Gross written premiums |
|
|
| ||||
Ceded written premiums | ( |
| ( |
| ( |
| ( |
Net written premiums |
|
|
| ||||
Net change in unearned premiums |
| ( |
| ( |
| ( | |
Net premiums earned |
|
|
| ||||
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses | ( |
| ( |
| ( |
| ( |
Net policy acquisition expenses | ( |
| ( |
| ( |
| ( |
Underwriting income |
|
|
| ||||
Supplementary Financial Information – Investment Yield (Unaudited) | ||||
| ||||
The following table shows the investment yield calculation: | ||||
|
|
| ||
| Quarter Ended | Year Ended | ||
(in millions of | 2025 | 2024 | 2025 | 2024 |
Investment income | ||||
Average total investments and cash and cash equivalents(i) | ||||
Investment Yield (annualized) | 4.4% | 4.4% | 4.2% | 4.3% |
(i) | Represents the average of the month end fair value balances of total investments and cash and cash equivalents in each reporting period. |
Note to the Consolidated Financial Statements (Unaudited) | ||||
| ||||
(1) Represents net income for the period available to common shareholders divided by the weighted average number of vested common shares – diluted calculated as follows: | ||||
| ||||
| Quarter Ended | Year Ended | ||
(in millions of | 2025 | 2024 | 2025 | 2024 |
Net income for the period | ||||
Minus: Net income attributable to the earnout shares | — | — | — | |
Minus: Dividends attributable to restricted share awards | — | — | ||
Net income available to common shareholders (a) | ||||
Weighted average number of vested common shares – diluted (in millions of shares) (b)* | 42.7 | 46.2 | 43.7 | 44.7 |
Diluted earnings per share attributable to equity holders (a/b) | ||||
* | The weighted average number of common shares refers to the number of common shares calculated after adjusting for the changes in issued and outstanding common shares over a reporting period. |
Non-GAAP Financial Measures
In presenting IGI’s financial results, management has included and discussed certain non-GAAP financial measures. We believe that these non-GAAP financial measures, which may be defined and calculated differently by other companies, help to explain and enhance the understanding of our results of operations. However, these measures should not be viewed as a substitute for those determined in accordance with
Reconciliation of Combined Ratio to Accident Year Combined Ratio Prior to CAT Losses
The table below illustrates the reconciliation of the combined ratio on a financial and accident year basis.
| Quarter Ended | Year Ended | ||
(In millions of | 2025 | 2024 | 2025 | 2024 |
Net premiums earned (a) | ||||
Net loss and loss adjustment expenses (b) | ( | ( | ( | ( |
Net policy acquisition expenses (c) | ( | ( | ( | ( |
General and administrative expenses (d) | ( | ( | ( | ( |
Prior years (favorable) development (e) | ( | ( | ( | ( |
Current accident year CAT losses (f)* | ||||
|
|
|
|
|
Combined ratio ((b+c+d)/a)** | 82.0% | 77.8% | 85.9% | 79.9% |
Minus: Prior years (favorable) development (e/a) | (5.2%) | (2.3%) | (7.9%) | (7.7%) |
Accident year combined ratio | 87.2% | 80.1% | 93.8% | 87.6% |
Minus: CAT losses on an accident year basis (f/a) | 11.7% | 6.0% | 13.0% | 9.2% |
Accident year combined ratio prior to CAT losses | 75.5% | 74.1% | 80.8% | 78.4% |
* | The CAT losses for the quarter and year ended | |
| ||
The CAT losses for the year ended | ||
| ||
The CAT losses for the quarter and year ended | ||
| ||
The CAT losses for the year ended | ||
| ||
| ||
** | See “Supplementary Financial Information - Combined Ratio (Unaudited)”. | |
Non-GAAP Financial Measures
The table below illustrates the split of loss ratio between current accident year, current accident year CAT losses, which are included in ‘Net loss and loss adjustment expenses’, and prior years’ loss development as follows:
| Quarter Ended | Year Ended | ||||||
| 2025 | 2024 | 2025 | 2024 | ||||
(in millions of | Net loss and | % of net | Net loss and | % of net | Net loss and | % of net | Net loss and | % of net |
Current Accident year losses (Prior to CAT losses) | 35.6% | 39.3% | 42.5% | 43.2% | ||||
Plus: Current accident year CAT losses | 11.7% | 6.0% | 13.0% | 9.2% | ||||
Plus: Effect of prior years’ favorable loss development | ( | (5.2%) | ( | (2.3%) | ( | (7.9%) | ( | (7.7%) |
Total | 42.1% | 43.0% | 47.6% | 44.7% | ||||
Core Operating Income
Core operating income measures the performance of our operations without the influence of after-tax gains or losses on investments and foreign currencies and other items as noted in the table below. We exclude these items from our calculation of core operating income because the amounts of these gains and losses are heavily influenced by, and fluctuate in part according to, economic and other factors external to the Company and/or transactions or events that are typically not a recurring part of, and are largely independent of, our core underwriting activities and including them distorts the analysis of trends in our operations. We believe the reporting of core operating income enhances an understanding of our results by highlighting the underlying profitability of our core insurance operations. Our underwriting profitability is impacted by earned premiums, the adequacy of pricing, and the frequency and severity of losses. Over time, such profitability is also influenced by underwriting discipline, which seeks to manage the Company’s exposure to loss through intelligent risk selection and diversification, IGI’s management of claims, use of reinsurance and the ability to manage the expense ratio, which the Company accomplishes through the management of acquisition costs and other underwriting expenses.
In addition to presenting net income for the period determined in accordance with
Non-GAAP Financial Measures
Core operating income is calculated by the addition or subtraction of certain line items reported in the “Consolidated Statements of Income” from net income for the period and tax effecting each line item (resulting in each item being a non-GAAP financial measure), as illustrated in the table below:
| Quarter Ended | Year Ended | ||
(in millions of | 2025 | 2024 | 2025 | 2024 |
Net income for the period | ||||
Reconciling items between net income for the period and core operating income: |
|
|
|
|
Net realized (gain) on investments | ( | ( | ( | ( |
Tax impact of net realized (gain) on investments(i) | — | — | — | |
Net unrealized loss (gain) on investments | ( | ( | ||
Tax impact of net unrealized loss (gain) on investments(i) | ( | ( | — | |
Change in allowance for expected credit losses on investments | — | ( | ( | — |
Tax impact of change in allowance for expected credit losses on investments(i) | — | — | — | |
Change in fair value of derivative financial liabilities | — | — | — | |
Net foreign exchange loss (gain) | ( | |||
Tax impact of net foreign exchange loss (gain)(i) | ( | ( | ( | |
Core operating income | ||||
Average shareholders’ equity (ii) | ||||
Core operating return on average equity (annualized) (iii) and (v) | 19.5% | 25.0% | 16.8% | 24.2% |
Diluted core operating earnings per share (iv) | ||||
Return on average equity (annualized) (v) | 18.5% | 18.4% | 18.6% | 22.6% |
i. | The tax impact was calculated by applying the prevailing corporate tax rate of each subsidiary to the gross value of the relevant reconciling items as recognized separately by the subsidiaries on a standalone basis. | |
| ||
ii. | Represents the total shareholders’ equity at the end of the reporting period plus the total shareholders’ equity as of the beginning of the reporting period, divided by 2. | |
| ||
iii. | Represents annualized core operating income for the period divided by average shareholders’ equity. |
Non-GAAP Financial Measures | ||||
iv. Represents core operating income attributable to vested equity holders divided by the weighted average number of vested common shares – diluted as follows: | ||||
| Quarter Ended | Year Ended | ||
(in millions of | 2025 | 2024 | 2025 | 2024 |
Core operating income | ||||
Minus: Core operating income attributable to earnout shares | — | — | — | |
Minus: Dividends attributable to restricted share awards | — | — | ||
Core operating income available to common shareholders (a) | ||||
Weighted average number of vested common shares – diluted (in millions of shares) (b) | 42.7 | 46.2 | 42.7 | 46.2 |
Diluted core operating earnings per share (a/b) | ||||
v. | Return on average equity (annualized) and core operating return on average equity (annualized), both non-GAAP financial measures, represent the returns generated on common shareholders’ equity during the period. |
The Company has posted a fourth quarter 2025 investor presentation deck on its website at www.iginsure.com in the Investors section under the Presentations & Webcasts tab.
---
About
---
Forward-Looking Statements:
This press release contains “forward-looking statements” within the meaning of the “safe harbour” provisions of the Private Securities Litigation Reform Act of 1995. The expectations, estimates, and projections of the business of
---
View source version on businesswire.com: https://www.businesswire.com/news/home/20260224094005/en/
IGI Investor & Media Contacts:
Email: robin.sidders@iginsure.com
Email: ahmad.jabsheh@iginsure.com
Source: